PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 1977Proceedings of the National Academy of Sciences73 citationsOpen Access

Identification of a purified complement-fixing antigen as the Epstein-Barr-virus determined nuclear antigen (EBNA) by its binding to metaphase chromosomes.

View Full Paper
SOShigeo OhnoJLJános LukaTLTomas Lindahl

Key Points

Key points are not available for this paper at this time.

Abstract

A soluble complement-fixing antigen carried by Epstein-Barr virus (EBV)-transformed human cells has been previously extracted from cell nuclei and purified by DNA-cellulose chromatography Luka, J., Siegert, W. & Klein, G. (1977) J. Virol., in press. On addition of this antigen to methanol/acetic acid-fixed metaphase chrmosomes, followed by exposure to human sera containing antibodies against the EBV-determined nuclear antigen (EBNA), brilliant positive staining was obtained by anti-complement immunofluorescence. There was no staining after exposure to EBV-negative sera. Moreover, a nuclear protein fraction, prepared from an EBV-negative cell line in an analogous fashion, failed to induce the staining reaction. These data identify the soluble purified antigen as the EBV-determined nuclear antigen. The purified antigen has a molecular weight of 174,000 +/- 15,000, as determined by sucrose gradient centrifugation and gel filtration experiments. In neutral buffers containing 0.5-1.0 M NaCl, the antigen dissociates into a form of approximately one-half the original molecular weight with retained complement-fixing activity. This "monomer" has a molecular weight of 98,000 +/- 8,000.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ohno et al. (1977) studied this question.

synapsesocial.com/papers/6a923a303da4caa5ce9635ddhttps://doi.org/10.1073/pnas.74.4.1605
Ask AI
Helpful
Bookmark
Share
View Full Paper